Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

O. Linder · SciRah

Researcher profile · Semantic Scholar

O. Linder

Share profile

O. Linder — researcher profile on SciRah

h-index: 22
Works: 53
Citations: 3,600

Most-cited papers

The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.
S. Schulman, S. Granqvist, M. Holmström, A. Carlsson +8 more
1997New England Journal of Medicine641 citations Open access
Semantic Scholar
Post‐thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months
S. Schulman, P. Lindmarker, M. Holmström, G. Lärfars +11 more
2006Journal of Thrombosis and Haemostasis513 citations Open access
Semantic Scholar
A Comparison of Six Weeks With Six Months of Oral Anticoagulant Therapy After a First Episode of Venous Thromboembolism
S. Schulman, A. Rhedin, P. Lindmarker, A. Carlsson +13 more
1996419 citations
Semantic Scholar
Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients.
E. Hellström-Lindberg, T. Ahlgren, Y. Beguin, Magnus Carlsson +15 more
1998Blood308 citations Open access
Semantic Scholar
Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.
M. Björkholm, A. Derolf, M. Hultcrantz, S. Kristinsson +11 more
2011Journal of Clinical Oncology244 citations Open access
Semantic Scholar
Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma.
A. Waage, P. Gimsing, P. Fayers, N. Abildgaard +21 more
2010Blood241 citations Open access
Semantic Scholar
Outcome and survival of myeloma patients diagnosed 2008–2015. Real-world data on 4904 patients from the Swedish Myeloma Registry
C. Blimark, I. Turesson, A. Genell, L. Ahlberg +8 more
2017Haematologica138 citations Open access
Semantic Scholar
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial.
P. Gimsing, K. Carlson, I. Turesson, P. Fayers +18 more
2010The Lancet Oncology121 citations Open access
Semantic Scholar
A phase II trial of pegylated interferon alpha-2b therapy for polycythemia vera and essential thrombocythemia: feasibility, clinical and biologic effects, and impact on quality of life.
J. Samuelsson, H. Hasselbalch, Ø. Bruserud, S. Temerinac +6 more
2006Cancer95 citations Open access
Semantic Scholar
Impact of age on survival after intensive therapy for multiple myeloma: a population‐based study by the Nordic Myeloma Study Group
S. Lenhoff, M. Hjorth, J. Westin, L. Brinch +14 more
2006British Journal of Haematology74 citations Open access
Semantic Scholar
A phase II study of vorinostat (MK‐0683) in patients with polycythaemia vera and essential thrombocythaemia
C. Andersen, M. McMullin, E. Ejerblad, S. Zweegman +16 more
2013British Journal of Haematology72 citations
Semantic Scholar
Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population‐based data from the Swedish Myeloma Register
H. Nahi, A. Genell, Göran Wålinder, K. Uttervall +11 more
2017European Journal of Haematology65 citations
Semantic Scholar
Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation.
S. Lenhoff, M. Hjorth, I. Turesson, J. Westin +15 more
2006Haematologica60 citations
Semantic Scholar
Negative Effect of DNA Hypermethylation on the Outcome of Intensive Chemotherapy in Older Patients with High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia following Myelodysplastic Syndrome
M. Grövdal, Rasheed Khan, A. Aggerholm, P. Antunović +14 more
2007Clinical Cancer Research59 citations Open access
Semantic Scholar
Maintenance treatment with azacytidine for patients with high‐risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy
M. Grövdal, M. Karimi, Rasheed Khan, A. Aggerholm +16 more
2010British Journal of Haematology58 citations Open access
Semantic Scholar
Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
L. Möllgård, L. Saft, M. Treppendahl, I. Dybedal +14 more
2011Haematologica55 citations Open access
Semantic Scholar
High‐dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia
H. Hallböök, B. Simonsson, T. Ahlgren, M. Björkholm +21 more
2002British Journal of Haematology55 citations
Semantic Scholar
Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study
M. Hjorth, O. Hjertner, L. Knudsen, N. Gulbrandsen +15 more
2012European Journal of Haematology49 citations Open access
Semantic Scholar
No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease
R. Hast, E. Hellström-Lindberg, L. Ohm, M. Björkholm +19 more
2003Leukemia36 citations Open access
Semantic Scholar
Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial
U. Mellqvist, J. Westin, P. Gimsing, O. Hjertner +22 more
200928 citations
Semantic Scholar
Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994–2009
S. Rosengren, U. Mellqvist, H. Nahi, Karin Forsberg +5 more
2016Bone Marrow Transplantation23 citations
Semantic Scholar
Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience
H. Hallböök, H. Hägglund, D. Stockelberg, P. Nilsson +6 more
2005Bone Marrow Transplantation23 citations Open access
Semantic Scholar
Intensive Treatment and Stem Cell Transplantation in Chronic Myelogenous Leukemia: Long-Term Follow-Up
B. Simonsson, G. Öberg, M. Björeman, M. Björkholm +22 more
2005Acta Haematologica22 citations
Semantic Scholar
Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase – a report from the Swedish CML Group
U. Axdorph, L. Stenke, G. Grimfors, J. Carneskog +10 more
2002British Journal of Haematology21 citations Open access
Semantic Scholar
Salvage bortezomib–dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial
P. Gimsing, O. Hjertner, N. Abildgaard, N. F. Andersen +8 more
2015Bone Marrow Transplantation17 citations Open access
Semantic Scholar
Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy
M. Groevdal, R. Kahn, M. Jansson, A. Aggerholm +10 more
200915 citations
Semantic Scholar
Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat.
C. Andersen, M. E. Bjørn, M. McMullin, C. Harrison +21 more
2014Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis14 citations
Semantic Scholar
Maintenance Treatment with Azacytidine for Patients with High Risk Myelodysplastic Syndromes or Acute Myeloid Leukaemia in Complete Remission after Intensive Chemotherapy.
M. Grövdal, Rasheed Khan, A. Aggerholm, P. Antunović +14 more
200712 citations
Semantic Scholar
Acquired hemophilia masked by warfarin therapy: report on two cases.
B. Uggla, O. Linder, S. Schulman
2003Blood Coagulation and Fibrinolysis12 citations
Semantic Scholar
A phase II trial of pegylated interferon α‐2b therapy for polycythemia vera and essential thrombocythemia
J. Samuelsson, H. Hasselbalch, Ø. Bruserud, S. Temerinac +6 more
200611 citations Open access
Semantic Scholar
Etoposide, doxorubicin, cyclophosphamide and high‐dose betamethasone (EACB) as outpatient salvage therapy for refractory multiple myeloma
M. Ohrling, M. Björkholm, A. Österborg, Gunnar Juliusson +23 more
1993European Journal of Haematology10 citations
Semantic Scholar
Outcome and characteristics of non‐measurable myeloma: A cohort study with population‐based data from the Swedish Myeloma Registry
Göran Wålinder, J. Samuelsson, P. Näsman, M. Hansson +10 more
2019European Journal of Haematology9 citations
Semantic Scholar
Higher Plasma but not Intracellular Concentrations After Infusion With Liposomal Daunorubicin Compared With Conventional Daunorubicin in Adult Acute Myeloid Leukemia
C. Löfgren, S. Lehmann, Kerstin Jönsson-Videsäter, L. Möllgård +4 more
2007Therapeutic Drug Monitoring9 citations
Semantic Scholar
Phase II study of cyclophosphamide, interferon-alpha and betamethasone (CIB) as induction therapy for patients 60-75 years of age with multiple myeloma stages II and III.
J. Lundin, A. Osterborg, M. Björkholm, B. Björkstrand +7 more
2003The Hematology Journal9 citations
Semantic Scholar
Cytokine Measurements for Diagnosing and Characterizing Leukemoid Reactions and Immunohistochemical Validation of a Granulocyte Colony-Stimulating Factor and CXCL8-Producing Renal Cell Carcinoma
M. Åström, Walid Tajeddinn, M. Karlsson, O. Linder +2 more
2018Biomarker Insights8 citations Open access
Semantic Scholar
A Phase II Study of Vorinostat (MK-0683) in Patients with Polycythemia Vera and Essential Thrombocythemia
C. Andersen, M. McMullin, E. Ejerblad, S. Zweegman +16 more
20128 citations
Semantic Scholar
A Phase II Trial of Pegylated Interferon -2b Therapy for Polycythemia Vera and Essential Thrombocythemia Feasibility, Clinical and Biologic Effects, and Impact on Quality of Life
J. Samuelsson, H. Hasselbalch, Ø. Bruserud, S. Temerinac +6 more
20068 citations
Semantic Scholar
Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival.
U. Olsson-Strömberg, B. Simonsson, T. Ahlgren, M. Björkholm +18 more
2004The Hematology Journal7 citations
Semantic Scholar
Real World Data In Myeloma: Experiences From The Swedish Population-Based Registry On 2494 Myeloma Patients Diagnosed 2008-2011
E. Holmberg, G. Juliusson, H. Nahi, F. Karin +6 more
20136 citations
Semantic Scholar
A Randomized Phase 2 Trial Comparing Carfilzomib-Dexamethasone Vs Observation As Maintenance after Induction with Carfilzomib-Cyclophosphamide-Dexamethasone in Salvage ASCT in Multiple Myeloma: A Trial By the Nordic Myeloma Study Group
H. Gregersen, Valdas Pečeliūnas, K. Remes, F. Schjesvold +16 more
2019Blood5 citations Open access
Semantic Scholar
A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony‐stimulating factor: significant effects on quality of life
E. Hellström-Lindberg, N. Gulbrandsen, Greger Lindberg, T. Ahlgren +16 more
2003British Journal of Haematology5 citations Open access
Semantic Scholar
Lenalidomide in High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia with Chromosome 5 Abnormalities
L. Möllgård, L. Nilsson, L. Kjeldsen, I. Dybedal +7 more
20094 citations
Semantic Scholar
Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase
U. Olsson-Strömberg, M. Höglund, M. Björkholm, I. Braide +23 more
2006Leukemia and Lymphoma4 citations
Semantic Scholar
Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy
M. Grövdal, Rasheed Khan, A. Aggerholm, P. Antunović +14 more
20083 citations
Semantic Scholar
A phase II trial of pegylated interferon alpha-2b therapy for polycythemia vera and essential thrombocythemia: feasibility, clinical and biological effects, and impact on quality of life
J. Samuelsson, H. Hasselbalch, Ø. Bruserud, S. Temerinac +6 more
20062 citations
Semantic Scholar
A Phase II Trial of Pegylated Interferon α-2b in Polycythemia Vera and Essential Thrombocythemia. Clinical Responses, Effects on PRV-1 Expression and Impact on Quality of Life.
J. Samuelsson, H. Hasselbalch, Ø. Bruserud, H. Pahl +12 more
20042 citations
Semantic Scholar
Carfilzomib and dexamethasone maintenance prolong time to progression following salvage ASCT in multiple myeloma
H. Gregersen, Valdas Pečeliūnas, K. Remes, F. Schjesvold +16 more
20191 citations
Semantic Scholar
A Phase II Study of Bortezomib-Dexametason Followed by High-Dose Melphalan Combined with Bortezomib in Patients Relapsing After High-Dose Melphalan with Autologous Stem Cell Support
P. Gimsing, O. Hjertner, N. Abildgaard, N. F. Andersen +7 more
20111 citations
Semantic Scholar
Synergistic effect of G-CSF and epo on the anaemia in patients with MDS. Evidence for increased erythropoietic effectiveness rather than expansion
E. Hellström-Lindberg, M. Carlsson, J. Carneskog, I. M. Dahl +12 more
19941 citations
Semantic Scholar
Over 10 years relative median survival in MM patients ≤ 65 years with VGPR or better on 1st line treatment. Population-based data on patients diagnosed 2008-2018 from the Swedish Myeloma Registry
C. Blimark, A. Genell, J. Lund, H. Nahi +10 more
2019Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

I. Turesson×16
Invite
I. Turesson — researcher profile on SciRah
K. Carlson×13
Invite
K. Carlson — researcher profile on SciRah
E. Löfvenberg×12
Invite
E. Löfvenberg — researcher profile on SciRah
J. Samuelsson×12
Invite
J. Samuelsson — researcher profile on SciRah

×12

Invite

M. Björkholm — researcher profile on SciRah

Invite

G. Öberg — researcher profile on SciRah

Invite

J. Tangen — researcher profile on SciRah

U. Mellqvist×10

Invite

U. Mellqvist — researcher profile on SciRah

Invite

H. Nahi — researcher profile on SciRah

E. Hellström-Lindberg×9

Invite

E. Hellström-Lindberg — researcher profile on SciRah

Invite

M. Hjorth — researcher profile on SciRah

Invite

G. Grimfors — researcher profile on SciRah